A validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone. (AVOID)
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2625136
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Dexamethasone 13.2mg/body i.v.(day1) Oxaliplatin 130mg/m2 i.v. (day1) Bevaciumab 7.5mg/Kg i.v. (day1) Capecitabine2,000mg/m2,p.o.(day1-14) to be repeated every 3 weeks
Primary outcome(s): Hypersensitivity reaction incidence
Study Design: Single arm Non-randomized
创建时间：
2013-01-15
